Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
about
Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligasesTargeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis.E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to DegenerationTargeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapyErbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesisEvaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumorTargeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic applicationRole of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.Targeting prohibitins induces apoptosis in acute myeloid leukemia cells.Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.Targeting neddylation in cancer therapy.Cullin-RING Ligases as attractive anti-cancer targets.MLN4924 therapy as a novel approach in cancer treatment modalities.Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation.Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.Protein neddylation and its alterations in human cancers for targeted therapy.
P2860
Q27027897-56B47836-533F-4D6B-B548-121D774845EDQ30525356-BEAB872D-FF98-4E06-8F1A-66CAA94CF3D6Q33705444-AAAF93BD-DFD5-4910-AFE6-BD8D9E7117F2Q34563129-B828FE27-83E6-466E-B78F-8E822934BDF9Q35697259-1CADAF9B-0DCA-4F0E-A657-9126C6736FE7Q35858428-AFF16B4E-2193-4076-B2E0-3BB4F15806DCQ36062128-1D100A8C-509B-431F-9CDA-C532E5AF4072Q37388126-F04191BA-F4B0-43AA-B327-D84A9E8F3406Q37662175-87F1C749-2012-478E-8A39-4F46131E417DQ38052131-1FE69CF7-BE22-43F4-91F4-56A6EBE8E47BQ38058483-6C23AFED-4233-4B92-8128-B20118430EB6Q38059505-CA31704E-6D95-4BEA-A793-6071FE385CDEQ38059746-6F234951-B120-4F3B-AA11-B8D6DC451662Q38570362-2A7D4B98-55A1-4F64-B23E-2E34D2571291Q39096559-7CA2398A-D30B-418D-846F-46B7172DB9BFQ41083946-9D3A208C-F3B7-4EE6-8563-36C0C08E0677Q41991525-6CA061A1-7500-4AB0-9E74-B52F7AADD62DQ48538797-6065F726-25E0-40E8-BA6F-A99CFAB059D1
P2860
Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@ast
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@en
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@nl
type
label
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@ast
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@en
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@nl
prefLabel
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@ast
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@en
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@nl
P2093
P2860
P1433
P1476
Inactivation of SAG E3 ubiquit ...... ukemia cells to retinoid acid.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0027726
P407
P577
2011-11-15T00:00:00Z